Search Results - "Kunisaki, R."

Intestinal amoebiasis in a patient with acute graft‐versus‐host disease after allogeneic bone marrow transplantation successfully treated by metronidazole by Numata, A., Itabashi, M., Kishimoto, K., Motohashi, K., Hagihara, M., Kuwabara, H., Tanaka, M., Kato, H., Chiba, S., Kunisaki, R., Fujisawa, S.

“…Amoebiasis has rarely been reported in patients undergoing hematopoietic stem cell transplantation, although it is a world‐wide infection and extremely common…”
Get full text

Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas by Kang, X, Xiao, X, Harata, M, Bai, Y, Nakazaki, Y, Soda, Y, Kurita, R, Tanaka, T, Komine, F, Izawa, K, Kunisaki, R, Setoyama, M, Nishimori, H, Natsume, A, Sunamura, M, Lozonshi, L, Saitoh, I, Tokino, T, Asano, S, Nakamura, Y, Tani, K

“…Glioblastomas are the most common primary brain tumors in adults. These tumors exhibit a high degree of vascularization, and malignant progression from…”
Get full text

Infliximab and the bone in Crohn's disease by Kunisaki, R., Chaki, O., Taguchi, T., Sugiyama, T., Sugita, A.

Get full text

Mice lacking a transcriptional corepressor Tob are predisposed to cancer by Yoshida, Yutaka, Nakamura, Takahisa, Komoda, Masato, Satoh, Hitoshi, Suzuki, Toru, Tsuzuku, Junko K, Miyasaka, Takashi, Yoshida, Eri H, Umemori, Hisashi, Kunisaki, Reiko K, Tani, Kenzaburo, Ishii, Shunsuke, Mori, Shigeo, Suganuma, Masami, Noda, Tetsuo, Yamamoto, Tadashi

“…tob is a member of antiproliferative family genes. Mice lacking tob are prone to spontaneous formation of tumors. The occurrence rate of…”
Get full text

P1189 Clinical features and surgical necessity rate of fistulising perianal disease in newly diagnosed patients with Crohn's disease: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD) by Takatsu, N, Yamamoto, T, Nakase, H, Shinzaki, S, Watanabe, K, Fujii, T, Okamoto, R, Matsuoka, K, Yamada, A, Kunisaki, R, Matsuura, M, Shiga, H, Bamba, S, Mikami, Y, Shimoyama, T, Motoya, S, Torisu, T, Kobayashi, T, Ohmiya, N, Saruta, M, Matsuda, K, Matsumoto, T, Maemoto, A, Yoshigoe, S, Tsuchiya, H, Nishimura, R, Murata, Y, Hisamatsu, T

“…Abstract Background Fistulising perianal diseases (FPD) are common in patients with Crohn's disease (CD) in Asia, but the treatment pattern and the proportion…”
Get full text

P419 Psychological acceptability of surgery in patients with ulcerative colitis after total colectomy by Itabashi, M, Hirano, Y, Saito, T, Inoue, M, Uchida, K, Arai, K, Minakuchi, E, Ishihara, H, Onizawa, R, Hirayama, A, Araki, K, Kimura, H, Kunisaki, R

“…Abstract Background The purpose of surgery for patients with ulcerative colitis (UC) is to save their lives and improve their quality of life (QOL). However,…”
Get full text

P183 Development of a new simple ultrasound activity score for intestinal Behçet's Disease by Yaguchi, K, Kunisaki, R, Sato, S, Izumi, M, Fukuno, Y, Ebina, T, Matsune, Y, Hama, T, Onishi, M, Kobayashi, K, Shibui, S, Toritani, K, Nishida, D, Matsubayashi, M, Nakamori, Y, Nishio, M, Umezawa, S, Ogashiwa, T, Sasaki, T, Fujii, A, Kimura, H, Numata, K, Maeda, S

“…Abstract Background Intestinal Behçet's disease (BD) is a relapsing-remitting disease typically associated with punched-out ulcers in the ileocecal region…”
Get full text

P775 Disease activity and treatment patterns of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD) by Shinzaki, S, Matsuoka, K, Fujii, T, Okamoto, R, Yamada, A, Kunisaki, R, Matsuura, M, Watanabe, K, Shiga, H, Takatsu, N, Bamba, S, Mikami, Y, Yamamoto, T, Shimoyama, T, Motoya, S, Torisu, T, Kobayashi, T, Ohmiya, N, Saruta, M, Matsuda, K, Matsumoto, T, Nakase, H, Maemoto, A, Murata, Y, Yoshigoe, S, Tsuchiya, H, Hisamatsu, T

“…Abstract Background Biologics are commonly used for the treatment of Crohn’s disase (CD); however, the proportion of biologics used and their initiation time…”
Get full text

P723 Comparison of the Persistence Rates of Biologic Agents in Paediatric Crohn's Disease Patients (Japanese Paediatric IBD Registry Study) by Nishida, D, Ishige, T, Arai, K, Shimizu, H, Iwama, I, Nambu, R, Kunisaki, R, Yaguchi, K, Mizuochi, T, Murakoshi, T, Saito, T, Kato, S, Kudo, T, Iwata, N, Inoue, M, Yodoshi, T, Hagiwara, S I, Toita, N, Tajiri, H, Mochizuki, T, Kakuta, F, Kumagai, H, Noguchi, A, Sasaki, M, Nishimata, S, Aomatsu, T, Hirano, Y, Shimizu, T

“…Abstract Background Biologics are widely used for paediatric Crohn's disease (CD) and are highly effective; however, primary inefficacy and the emergence of…”
Get full text

P780 Prognosis and optimal treatment for 5-aminosalicylic acid-intolerant patients with Ulcerative Colitis by Yaguchi, K, Kinoshita, H, Kunisaki, R, Madarame, A, Tatsuno, M, Nishikawa, Y, Hama, T, Onishi, M, Kobayashi, K, Shibui, S, Toritani, K, Nishida, D, Matsubayashi, M, Nakamori, Y, Nishio, M, Umezawa, S, Ogashiwa, T, Sasaki, T, Fujii, A, Kimura, H, Kato, J, Maeda, S

“…Abstract Background 5-aminosalicylic acid (5-ASA) is widely used as a first-line treatment for ulcerative colitis (UC), but intolerance sometimes occurs…”
Get full text

P720 Efficacy of exclusive enteral nutrition for induction and partial enteral nutrition for maintenance of remission in newly diagnosed paediatric and adolescent Crohn’s disease by Ikeda, A, Ogashiwa, T, Nakamori, Y, Mitsui, T, Chida, K, Hashimoto, Y, Tamura, Y, Maeda, S, Kimura, H, Kunisaki, R

“…Abstract Background Exclusive enteral nutrition (EEN) is beneficial for inducing remission in children, and is recommended as the first-line therapy for…”
Get full text

Self-Reported Medication Adherence Among Patients with Ulcerative Colitis in Japan and the United Kingdom: A Secondary Analysis for Cross-Cultural Comparison by Kawakami, Aki, Tanaka, Makoto, Choong, Lee Meng, Kunisaki, Reiko, Maeda, Shin, Bjarnason, Ingvar, Hayee, Bu'Hussain

“…Non-adherence to medication was reported by 28% of Japanese patients with ulcerative colitis, but in the United Kingdom, patients with inflammatory bowel…”
Get full text

P276 Prevalence, clinicopathological, and biological characteristics of serrated polyps in patients with ulcerative colitis by Nishio, M, Kunisaki, R, Shibata, W, Ajioka, Y, Hirasawa, K, Takase, A, Chiba, S, Inayama, Y, Ueda, W, Okawa, K, Tsunoda, S, Azuma, D, Yaguchi, K, Fujii, K, Nakamori, Y, Madarame, A, Nishida, D, Fuse, M, Araki, K, Saigusa, Y, Kimura, H, Kato, J, Maeda, S

“…Abstract Background Serrated polyps are recognized as precursors of colorectal cancer in general population and have recently been reported in patients with…”
Get full text

P291 Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study by Ikeda, A, Kunisaki, R, Aoki, S, Yaguchi, K, Asami, S, Furusawa, K, Atsusaka, R, Azuma, D, Tsunoda, S, Fujii, K, Nishida, D, Madarame, A, Nishio, M, Ogashiwa, T, Nakamori, Y, Fuse, M, Daibo, S, Araki, K, Kimura, H, Suzuki, R, Go, H, Saigusa, Y, Maeda, S

“…Abstract Background Current consensus statements recommend at least 3–6 months of preconception steroid-free remission for women with inflammatory bowel…”
Get full text

P337 Efficacy of intravenous cyclosporine in fulminant steroid-refractory ulcerative colitis with massive bleeding: a retrospective, observational study by Ogashiwa, T., Nishio, M., Otake, H., Inoue, E., Kimura, H., Kunisaki, R.

Get full text

P489 Double-dose infliximab therapy in Crohn's disease: appropriate time to evaluate the efficacy, long-term efficacy and safety by Kunisaki, R., Nishio, M., Ogashiwa, T., Otake, H., Inoue, E., Kimura, H.

Get full text

P172 Clinical characteristics of newly diagnosed adult patients with Crohn’s disease in Japan: Interim analysis of Inception cohort registry study of patients with Crohn’s disease (iCREST-CD) by Matsuoka, K, Fujii, T, Okamoto, R, Yamada, A, Kunisaki, R, Matsuura, M, Watanabe, K, Shiga, H, Takatsu, N, Bamba, S, Mikami, Y, Yamamoto, T, Shimoyama, T, Motoya, S, Torisu, T, Kobayashi, T, Ohmiya, N, Saruta, M, Matsuda, K, Matsumoto, T, Nakase, H, Maemoto, A, Shinzaki, S, Murata, Y, Yoshigoe, S, Sasaki, A, Yajima, T, Hisamatsu, T

“…Abstract Background Information on patient demographics and disease characteristics at the time of Crohn’s disease (CD) diagnosis is considered to be an…”
Get full text

P415 Paradoxical onset of Takayasu’s arteritis in patients with inflammatory bowel disease treated with anti-tumour necrosis factor-α agents by Matsune, Y, Kouyama, J, Tsuru, Y, Shimizu, K, Asami, S, Matsuyama, S, Katsuki, S, Ishihara, H, Onizawa, R, Shonai, S, Tatsuno, M, Nishikawa, Y, Takeuchi, K, Watanabe, M, Nakamori, Y, Hirayama, A, Toyoda, J, Ikeda, A, Madarame, A, Nishio, M, Ogashiwa, T, Matsubayashi, M, Fujii, A, Kimura, H, Kunisaki, R

“…Abstract Background Takayasu’s arteritis (TA) is a rare complication associated with inflammatory bowel disease (IBD). TA is a granulomatous systemic…”
Get full text

P671 Natural history and clinical outcomes of patients with ulcerative colitis who are intolerant to 5-aminosalicylic acid agents: A multi-centre cohort study by Madarame, A, Kinoshita, H, Yamaguchi, T, Izumi, Y, Nishikawa, Y, Shonai, S, Tatsuno, M, Ishii, Y, Yaguchi, K, Nakamori, Y, Ikeda, A, Araki, K, Hirayama, A, Ogashiwa, T, Fuji, A, Suzuki, R, Kimura, H, Kunisaki, R

“…Abstract Background Five-aminosalicylic acid (5-ASA) compounds are used as the primary treatment for ulcerative colitis (UC); however, some patients are…”
Get full text

P670 Therapeutic efficacy and economic impact of half sulfasalazine therapy for refractory ulcerative colitis by Kunisaki, R, Tatsuno, M, Kouyama, J, Kawamoto, C, Nishioka, H, Mizoguchi, A, Nakamori, Y, Mitsui, T, Chida, K, Hashimoto, Y, Tamura, Y, Ikeda, A, Ogashiwa, T, Suzuki, R, Maeda, S, Kimura, H

“…Abstract Background Numerous novel biologics are emerging for refractory ulcerative colitis (UC), but rising medical costs are a serious problem. Sulfasalazine…”
Get full text